Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Out of $LGND's Ibox: ROCHE CONTINGENT VALUE RIGHTS ($LGNDZ)
So let me try to explain this to you in lame mans terms. Here, look at the market cap, look at the cash in hand, look at the cash in value and look at the income of the LGND.
Of all the big boards that you own or have traded, show me a stock that is relatively what this stock shows on the statistics, none of them will come remotely close to cash
value or book value of this stock, guaranteed. Not to mention the institutional holding on this ticker, the names involved is astonishing to say the least. So now going into LGNDZ,
which is also severely undervalued by at least bare minimum 1000% from here, in all reality this should be trading at par value of 10% what the commons are trading, $7.00,
because this ticker LGNDZ is a CVR and if you don't what CVR is, look it up on Google, I already posted on the board, but if one doesn't read those post, which leads me to believe
anyone with low attention span reads the top 4 or 5, you need to read the stickies and the most important posts with links, this ticker is tied to LGND,
which means if the stock hit 330 dollars and change on or before 2023-2024, this is basically an option that you are making a call that the stock will hit those
numbers on or before or by the expiration date. Bottom Line LGNDZ is tied to LGND and certain events need to happen at certain time frame, meaning acquisitions,
FDA approval, any catalyst that move the commons up to reach that strike point.
GLTYA.
i'm in those, but what do you see?
sorry , i am a young man (70 years )
can you explain please ?
Ligand Pharmaceutica (LGND)
134.82 ? -4.5 (-3.23%)
Volume: 200,598
$LGNDZ +66.67%
Ligand Pharmaceuticals Incorporated
Rights - Roche Contingent Value Right
@$0.011
+0.0044 (+66.67%)
B/A: $0.0066 / 0.011 (1 x 1)
which is better : LGND or LGNDZ ?
Again another nice rise, keep em comming
One have to love such chart
https://ih.advfn.com/stock-market/NASDAQ/ligand-pharmaceuticals-LGND/stock-news/85737571/quarterly-report-10-q
Enjoy it and bank profit from it
There continues to be many trading opportunities
LGND—GLTU/A
LGND Ligand Pharmaceuticals
123.63 ? 2.8 (2.32%)
Volume: 112,200
Ligand Pharmaceutica (LGND)
117.7 ? 0.21 (0.18%)
Volume: 122,968
Ligand Pharmaceutica (LGND)
130.62 ? 4.14 (3.27%)
Volume: 148,583 @05/07/21 4:54:33 PM EDT
Bid Ask Day's Range
128.0 134.45 127.1 - 131.56
LGND Detailed Quote
News. Ligand, Lupin settle patent case over Evomela. Is this why LGNDZ has had some movement the last two days?
Gilead To Scale Up Remdesivir Availablity In India
April 27 2021 - 03:17AM
TipRanks
Biopharmaceutical company Gilead Sciences is expanding the availability of its COVID-19 treatment Remdesivir in India amid the country’s spike in cases. Gilead (GILD) is providing technical assistance and support for setting up new local manufacturing plants. The company is also donating the active pharmaceutical ingredient (API) to local facilities to help increase the production of the drug in India. Additionally, the company is donating at least 450,000 vials of Veklury to help Indian patients. Remdesivir is marketed in the US under the brand name Veklury.
https://www.tipranks.com/news/gilead-to-scale-up-remdesivir-availablity-in-india
Been here trading from the $70’s to $200+
I’m good.
GLTU/A
Nice! You surely meant $.10 as a little starter, right!? Go $LGNDZ
$LGNDZ: Added now at $0.025
Heading back over $0.10 soon enough
GO $LGNDZ
$LGND 154.6 ? 2.15 (1.41%) Volume: 120,331
Followers
|
55
|
Posters
|
|
Posts (Today)
|
0
|
Posts (Total)
|
3729
|
Created
|
05/09/16
|
Type
|
Free
|
Moderators |
Four OmniAb® therapeutic antibody platforms, OmniRat®, OmniFlic®, OmniMouse® and OmniChicken™, that produce highly diversified, fully human antibody repertoires optimized in vivo for manufacturability, therapeutic efficacy and reduced immunogenicity.
More about this technology: https://www.ligand.com/technologies/omniab
OMNIAB/Website: https://www.omniab.com/
Captisol® is a patent-protected, uniquely modified cyclodextrin, whose chemical structure was rationally designed to enable the creation of new products by significantly improving solubility, stability, bioavailability and dosing of active pharmaceutical ingredients (APIs).
More about this technology: https://www.ligand.com/technologies/captisol
CAPTISOL/Website: https://www.captisol.com/
LTP Technology™ is a broadened novel pro-drug technology platform designed to selectively deliver a range of active pharmaceutical agents to the liver.
More about this technology: https://www.ligand.com/technologies/ltp-technology
Ligand’s Pelican Expression Technology platform is utilized to develop next-generation and novel protein therapeutics, to improve existing therapies and create new therapies for biological targets linked to critical, unmet diseases. The proprietary platform uses P. fluorescens bacterium, which are especially well-suited for complex, large-scale protein production that cannot be made by more traditional host systems. The technology can contribute significant value to biopharmaceutical development programs by reducing development timelines and costs for manufacturing human therapeutics and vaccines
More about this technology: https://www.ligand.com/technologies/protein-expression-platform
PELICAN/Website: https://pelicanexpression.com/
Volume | |
Day Range: | |
Bid Price | |
Ask Price | |
Last Trade Time: |